본 연구는 경기지역 도축돈 및 도축우의 폐렴병변에서 Mycoplasma spp.의 발생 분포를 조사하고자 수행하였다. 부천 소재 도축장에 출하된 소와 돼지의 폐에 대하여 육안적 검사를 하고, 이 중 병변을 보인 소 192두와 돼지 257두의 폐에 대한 PCR 검사 결과, Mycoplasma spp.는 소에서 147두(76.5%), 돼지에서는 203두(80.9%) 에서 각각 검출되었다. 소, 돼지 각각의 Mycoplasma spp.에 대한 세부 primer를 이용한 검사 결과에서는 소에서 M. agalactiae가 16두(8.3%)에서 검출되었으나, M. dispar, M. bovis 및 M. bovirhinis는 검출되지 않았다. 돼지에서는 M. hyo-pneumoniae가 74두(28.8%), M. hyorhinis가 13두(5.1%) 검출되었다. M. hyosynoviae는 검출되지 않았다. 본 연구를 통해 경기지역 도축우 및 도축돈에서 Mycoplasma성 폐렴이 상재하고 있음을 확인하였다.
Mycoplasma spp. are extracellular bacteria that colonize on the respiratory epithelium of humans and animals. It is a causative agent of pneumonia commonly complicated by opportunistic infectious bacteria. Mycoplasma spp. infection cause relatively mild disease in the absence of environmental stressors, but when complicated by secondary bacterial invaders the resultant disease can cause obvious clinical disease and severe production losses in intensively reared pigs Mycoplasma spp. are highly fastidious bacteria, difficult to culture and slow growing. Many species of Mycoplasma spp. are important pathogens causing respiratory infection in animals and known to induce huge economic losses. The aims of the present study were to develop a rapid isolation and culture method of wild type Mycoplasma spp. in pigs. We used Mycoplasma spp. genus specific direct PCR without DNA extraction procedure using PhireⓇ Animal Tissue Direct PCR Kit from the lung tissues with pneumonia lesions. Therefore, we could save the time for tissue processing and increase the accuracy of Mycoplasma spp. inclusion prediction in lung tissues. Thereafter, we used the optimized media to isolate and culture Mycoplasma spp. As the results, Mycoplasma spp. could be isolated and cultured quickly and efficiently. These results could provide an efficient strategy and method for the rapid and accurate isolation and culture of wild type Mycoplasma spp. in pigs.
Mycoplasma (M.) felis and M. canis is related with pneumonia or conjunctivitis in domestic cats and several diseases in a variety of other animals, including lower respiratory tract disease or pleuritis. Polymerase chain reaction (PCR) assays has been reported as an easy and useful method. It could be conducted even on nasal swab samples as a non-invasive rapid testing tools for large numbers of Mycoplasma species. However, PCR assays have to conduct multiple assays because of a lot of Mycoplasma species. Therefore, it need to perform several tests and reveal time consuming procedures. In this study, we developed a sensitive and specific multiplex polymerase chain reaction (PCR) assay that detects simultaneously two species like as M. felis and M. canis. The simultaneous detection of M. felis and M. canis primers were used to differentiate two mycoplasma species. The target DNA fragments were specifically amplified M. felis and M. canis PCR with 16S ribosomal DNA primers. Single and mixed Mycoplasma species DNA templates were submitted to validate the specificity of the multiplex PCR. The corresponding specific DNA products were amplified for each pathogen. The detection limit of the developed multiplex PCR is 102 pg with M. felis and M. canis DNA. Furthermore, the developed multiplex PCR detected successfully M. felis in feline nasal specimens. The multiplex PCR assay provides a novel tool for simultaneous detection and differentiation of M. felis and M. canis in cats.
Mycoplasma hyorhinis (M. hyorhinis) is considered an etiological agent of arthritis in suckling pigs. Recently, some M. hyorhinis strains were shown to produce pneumonia that is indistinguishable from the mycoplasmosis caused by M. hyopneumoniae. In this study, we developed a sensitive and specific PCR assay to detect M. hyorhinis and applied the developed PCR assay for detection of Mycoplasma infection in clinical piglets infected with M. hyorhinis. We developed a new PCR assay using a M. hyorhinis-specific primer pair, Mrhin-F and Mrhin-R, designed from the Mycoplasma 16S-23S rRNA internal transcribed spacer (ITS) region. The primers and probe for the assay were designed from regions in the Mycoplasma 16S-23S rRNA ITS unique to M. hyorhinis. The developed PCR assay was very specific and sensitive for the detection of M. hyorhinis. The assay could detect the equivalent of 1 pg of target template DNA, which indicates that the assay was very sensitive. In addition, M. hyorhinis PCR assay detected only M. hyorhinis and not any other Mycoplasma or bacterial spp. of other genera. The new developed PCR assay effectively detected M. hyorhinis infection in pigs. We suggest that this PCR assay using a M. hyorhinis-specific primer pair, Mrhin-F and Mrhin-R, could be useful and effective for monitoring M. hyorhinis infection in pigs.
Mycoplasma (M.) hyopneumoniae is the causative agent of swine enzootic pneumonia, a disease that is prevalent in every country where pigs are raised. In this study, we aimed to develop a sensitive and specific PCR assay to detect M. hyopneumoniae in pigs. The suitability of this PCR assay for the detection of mycoplasmal infection was also tested using clinical lung samples from slaughtered pigs. We de- veloped a probe and M. hyopneumoniae-specific primer pairs, MhyoP-F and MhyoP-R, for the new PCR assay based on regions in the Mycoplasma protein P97 gene that are unique to M. hyopneumoniae. The developed PCR as- say was very specific and sensitive for the detection of M. hyopneumoniae. The assay was able to detect the equivalent of 10 pg of target template DNA, which indicates that the assay was very sensitive. In addition, the M. hyopneumoniae PCR assay detected only M. hyopneumoniae and no other Mycoplasma spp. or bacterial species of another genera. Further, the newly developed PCR assay effectively detected M. hyopneumoniae infection in pigs. We suggest that this PCR assay using M. hyopneumoniae-specific primer pairs, MhyoP-F and MhyoP-R, will be useful and effective for monitoring M. hyopneumoniae infection in pigs.
Mycoplasma hyopneumoniae (M. hyopneumoniae) is one of the causative bacteria that can induce chronic enzootic pneumonia, resulting in low production in the swine industry. Potentiation of porcine reproductive and respiratory syndrome virus-induced pneumonia by M. hyopneumoniae has also been recognized. Although some available vaccines have been developed for prevention of M. hyopneumoniae infection, protective immunity is still poor. In this study, in order to provide valuable information on vaccine antigen, we investigated the immunogenicity of M. hyopneumoniae on mouse spleen cells. Concanavalin A (ConA) and lipopolysaccharide (LPS) were used for generation of activated T and B lymphocytes. M. hyopneumoniae made clusters of spleen cells and also affected the cellular activity and viability of spleen cells by alone or with mitogens. Of particular interest, it induced a significant increase in production of TNF-alpha in ConA- treated spleen cells, meaning T helper 1 response. In addition, cell size and mitochondrial membrane potential of M. hyopneumoniae–treated spleen cells were measured by flow cytometric analysis. M. hyopneumoniae did not affect the cell size by alone, whereas ConA or LPS profoundly increased the cell size. Taken together, M. hyopneumoniae significantly affect the cellular activity and cytokine production of spleen cells by alone or in a combination of ConA. This study provides valuable information for production of the vaccine against M. hyopneumoniae.
대추나무빗자루병 매개충인 마름무늬매미충(Hish[monus sellatus Uhler)의 생태, 혼식 및 산란 호성, 기주이동, 월동태를 조사한 결과 남부지방에서 연 5세대가 경과되었고, 제 1세대 6월 중 ~하순, 2세대 7월 중~8월 상순, 3세대 8월 중~하순, 4세대 9월 상~중순, 5세대 10월 상~중순이었고, 최대 발생기는 3화기인 8월 중~하순이었다. 계절에 따른 한 세대에 요하는 기간은 춘계 80, 하계 69, 추계 77.8일이었으며, 각 단계별 크기는 란 0.8 mm, 1령충 0.9mm, 2령충 l.4mm. 3령충 2.1mm, 4령충2.5mm, 5령충 3.2 mm 이었으며 성충 암컷 4.1mm, 수컷 3.8mm였다. 년중을 통한 기주식물의 이동을 보면 주로 뽕나무, 환삼덩굴, 대추나무에서 란으로 월동하며, 5월 중~하순경까지 뽕나무와 환삼덩굴의 신호를 계속 증가하면서 일부가 6월 하순~7월초순경에 대추나무로 이동하며 가해하는데 이들 란이 10월 중~하순 경부터 월동태로 들어간다. 산란부위는 신초, 엽병, 엽통 등이며 1마리의 암컷 산란수는 32~62개였다. 파식선호성에서는 환삼덩굴, 대추나무, 쥐똥나무, 뽕나무에서 높은 선호성(38.2S-21.64 %)을 보였고 닥나무, 개머루, 구기자나무, 구지뽕나무, 모시풀, 벼, 골담초, 일일초, 차풀 등이 4.65~2.48%였다, 산란이호성에서는 식이호성이 높은 환삼덩굴, 뽕나무, 대추나무에서 24~12개 정도였으며 성충의 생명에서는 환삼덩굴, 뽕나무, 대추나무에서 41.4~44.4일, 개멀, 차풀, 쥐똥나무, 일일초, 자운영, 샐러리에서 25일 이상이었고 기지 기주식물에서는 20일 이하이었다.
Several bacterial species from the Burkholderia cepacia complex (Bcc) are opportunistic pathogens that lead to infections in patients with underlying lung disease, such as cystic fibrosis, as well as in immunocompromised individuals. Included in the Bcc, Burkholderia contaminans is an emerging pathogen in cystic fibrosis patients. However, this is the first report case of sepsis due to Burkholderia contaminans without cystic fibrosis in child. And we report that successful treatment of sepsis due to Burkholderia contaminans in the child, through antibiotic therapy.
Coronary artery complications are the most severe complications in Kawasaki disease (KD). Its cause is unclear but superantigens are considered to influence KD. This study aimed to determine whether coronary artery complications and level of Nterminal pro-brain natriuretic peptide (NT-proBNP) are associated with Mycoplasma pneumoniae (MP) in patients with KD. We studied 142 pediatric patients diagnosed with KD. MP immunoglobulin M (IgM) antibody examination was conducted. All patients underwent echocardiography, and coronary artery dilatation was defined as a coronary Z-score >2.0. We also evaluated their NT-proBNP findings. The independent t-test and Pearson chi-squared test were used to analyze betweengroup differences; a p-value <0.05 was considered statistically significant. Forty children were MP IgM positive. MP IgMpositive patients were older than MP IgM-negative patients. There was no significant difference in the clinical manifestations between the groups. Comparison of the mean Z-score of the coronary artery revealed that only the Z-score of the left anterior descending artery was significantly different between the groups. However, the number of patients with coronary artery dilatation was not significantly different between the groups. Our findings demonstrated no relationship between MP infection and coronary artery dilatation or NT-proBNP levels in patients with KD.
The present study aimed to identify the factors that can clinically predict responses to macrolides treatment in patients with Mycoplasma pneumoniae pneumonia. Of the patients admitted to the pediatrics department of Kwangju Christian Hospital during December 2012 to March 2015, 195 patients who had pneumonia according to findings of chest radiography, positive Mycoplasma IgM, and fever at the time of admission were selected as study subjects. Patients were divided into one group wherein the duration of fever after macrolides treatment was 3 days or less and another group wherein the duration of fever was 4 days or more (169 patients [86.7%] vs 26 patients [13.3%]). In the group with fever duration of 4 days or more, a greater number of patients had a history of atopic dermatitis (3.6% vs 15.4%, p=0.11), and the symptom duration before admission was longer (cough: 4.04 days vs 6.38 days, p<0.001; fever: 3.96 days vs 6.08 days, p<0.001). Moreover, according to laboratory test results in the group with fever duration of 4 days or more, LDH levels were high (648.16 IU/L vs 829.92 IU/L, p=0.001), and there was a significant correlation between LDH levels and the duration of fever after macrolides treatment.
Prevalence of Mycoplasma pneumoniae pneumonia in preschool children has shown a recent increase and macrolideresistant Mycoplasma pneumoniae pneumonia has been reported. We investigated the clinical features of Mycoplasma pneumoniae pneumonia among children of different ages and different years for the most recent seven years. Retrospective analysis was performed on the clinical data of 735 children who were hospitalized due to Mycoplasma pneumoniae pneumonia between January 2006 and December 2012. The children were divided into three groups according to age: the A group (<3 years), B group (≥3 years and <7 years), and C group (≥7 years). In addition, the children were divided into two groups according to the year in which the disease had developed: the early period (2006 and 2007 year), and the late period (from 2010 to 2012 year). The infant group (A group) presented mainly with a shorter duration of fever and more frequent wheezing. In the late period, the interval until improvement after a macrolide was prescribed increased. Clinical features of Mycoplasma pneumoniae pneumonia differed among children of different ages, particularly between infants and school-aged children.